Capstone Therapeutics Corp
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capsto… Read more
Capstone Therapeutics Corp (CAPS) - Total Liabilities
Latest total liabilities as of September 2024: $53.46 Million USD
Based on the latest financial reports, Capstone Therapeutics Corp (CAPS) has total liabilities worth $53.46 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Capstone Therapeutics Corp - Total Liabilities Trend (2005–2023)
This chart illustrates how Capstone Therapeutics Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Capstone Therapeutics Corp Competitors by Total Liabilities
The table below lists competitors of Capstone Therapeutics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Abeo SA
STU:4A8
|
Germany | €194.37 Million |
|
One and One Green Technologies. Inc Class A Ordinary Shares
NASDAQ:YDDL
|
USA | $24.59 Million |
|
PEAB -B-
BE:PEKB
|
Germany | €33.81 Billion |
|
Kodiak AI, Inc. Common Stock
NASDAQ:KDK
|
USA | $174.16 Million |
|
BCP Investment Corp.
NASDAQ:BCIC
|
USA | $314.49 Million |
|
VIA optronics AG
PINK:VIAOY
|
USA | $82.23 Million |
Liability Composition Analysis (2005–2023)
This chart breaks down Capstone Therapeutics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -27.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Capstone Therapeutics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Capstone Therapeutics Corp (2005–2023)
The table below shows the annual total liabilities of Capstone Therapeutics Corp from 2005 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $50.26 Million | -11.88% |
| 2022-12-31 | $57.04 Million | +4.45% |
| 2021-12-31 | $54.61 Million | +11.30% |
| 2020-12-31 | $49.07 Million | +1061.05% |
| 2019-12-31 | $4.23 Million | +55.31% |
| 2018-12-31 | $2.72 Million | +11.15% |
| 2017-12-31 | $2.45 Million | +87.73% |
| 2016-12-31 | $1.30 Million | +3.41% |
| 2015-12-31 | $1.26 Million | +347.16% |
| 2014-12-31 | $282.00K | +182.00% |
| 2013-12-31 | $100.00K | -65.99% |
| 2012-12-31 | $294.00K | +147.06% |
| 2011-12-31 | $119.00K | -93.45% |
| 2010-12-31 | $1.82 Million | -24.55% |
| 2009-12-31 | $2.41 Million | +20.83% |
| 2008-12-31 | $1.99 Million | -17.03% |
| 2007-12-31 | $2.40 Million | -30.22% |
| 2006-12-31 | $3.44 Million | -17.38% |
| 2005-12-31 | $4.17 Million | -- |